SAQ Training Versus Small-Sided Games for Cardiovascular Adaptations in Youth Football Players (SAQ-SSG)
Comparative Effects of Speed, Agility, and Quickness Training and Small-Sided Games on Cardiovascular Response in Youth Football Players: A Randomized Controlled Trial
調査の概要
詳細な説明
Football training methods may induce different physiological and cardiovascular adaptations in youth athletes. Speed, Agility, and Quickness (SAQ) training is widely used to enhance neuromuscular performance, while Small-Sided Games (SSGs) provide sport-specific training stimuli that combine technical, tactical, and physical demands.
The purpose of this randomized controlled trial was to compare the effects of SAQ training and SSGs on cardiovascular responses in youth football players. Thirty-six male football players aged 14-16 years were randomly allocated to one of three groups: an SAQ training group, an SSG group, or a control group. The intervention lasted 8 weeks.
Cardiovascular measurements included resting heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial pressure. Assessments were conducted before and after the intervention period. The study investigated whether SAQ training and SSGs produce different cardiovascular adaptations and whether either intervention is superior to regular football training for improving cardiovascular health indicators in youth football players.
This study was conducted in accordance with institutional ethical approval and informed consent procedures.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Qalyubia Governorate
-
Banhā、Qalyubia Governorate、エジプト、13111
- Benha Sporting Club
-
-
参加基準
適格基準
就学可能な年齢
- 子
健康ボランティアの受け入れ
説明
Inclusion Criteria:
Male football players aged 14 to 16 years. Minimum of 2 years of organized football training experience. Regular participation in football training at least 3 times per week. Ability to participate in all training sessions and assessments. Written informed consent provided by participants and their parents or legal guardians.
Exclusion Criteria:
Musculoskeletal injury within the previous 3 months. History of cardiovascular disease. Metabolic disorders. Neurological disorders. Use of medications that could affect cardiovascular responses or physical performance.
Failure to complete the intervention or assessment procedures.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：他の
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：SAQ Training Group
Participants received the SAQ training intervention for 8 weeks
|
Participants completed an 8-week Speed, Agility, and Quickness (SAQ) training program designed to improve movement efficiency, agility, acceleration, and cardiovascular adaptations.
Training sessions were integrated into the regular football training schedule and were performed throughout the intervention period
|
|
実験的：Small-Sided Games Group
Participants received the Small-Sided Games training intervention for 8 weeks
|
Participants completed an 8-week Small-Sided Games (SSG) training program involving soccer-specific game-based exercises performed in reduced playing areas.
The intervention was designed to provide technical, tactical, and physiological training stimuli and to promote cardiovascular adaptations.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Resting Heart Rate
時間枠：Baseline and Week 8
|
Resting heart rate measured in beats per minute (bpm)
|
Baseline and Week 8
|
|
Exercise Heart Rate
時間枠：Baseline and Week 8
|
Heart rate measured immediately after completion of the 20-meter shuttle run test.
|
Baseline and Week 8
|
|
Resting Diastolic Blood Pressure
時間枠：Baseline and Week 8
|
Resting diastolic blood pressure measured in mmHg.
|
Baseline and Week 8
|
|
Resting Systolic Blood Pressure
時間枠：Baseline and Week 8
|
Resting systolic blood pressure measured in mmHg.
|
Baseline and Week 8
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- REF:3/26
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。